There was little statistical evidence of an association between HMGCR or NPC1L1 inhibition and sarcopenia risk (including ALM and LHGS) in either set of genetic instruments, and sensitivity MR analyses showed consistent estimates, with no statistical evidence of bias from horizontal pleiotropy. Here, NPC1L1 is linked to sarcopenia.